Track 03: HIV Vaccines


An AIDS antibody doesn't yet exist, however endeavors to build up an immunization against HIV, the infection that causes AIDS, have been in progress for a long time. A HIV antibody could be viable in both of two different ways. A "preventive" immunization would stop HIV contamination happening through and through, while a "remedial" antibody would not stop disease, however would counteract or postpone ailment in individuals who do get tainted, and may likewise lessen the danger of them transmitting the infection to others. Albeit a preventive antibody would be perfect, helpful immunizations would likewise be exceptionally gainful. The fundamental thought behind all HIV immunizations is to empower the human invulnerable framework to battle HIV.


  • BNT162b2/COMIRNATY Tozinameran (INN)-BioNTech Manufacturing GmbH
  • AZD1222 Vaxzevria --AstraZeneca, AB

Related Conference of Track 03: HIV Vaccines

September 08-09, 2025

45th Global Summit and Expo on Vaccines & Immunology

Frankfurt, Germany
September 08-09, 2025

6th International Conference on Vaccine Research

Paris, France
September 18-19, 2025

7th World Congress on Vaccine and Immunology

Amsterdam, Netherlands
October 06-07, 2025

37th Annual Congress on Vaccine and Clinical Trials

Vancouver, Canada

Track 03: HIV Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in